There are a ton of people here telling you their accountants telling you otherwise, mine included.
I think it would be much more helpful if you tried avoiding stating this as objective truth, and state more like your non-accountant opinion is that's how it works.
It essentially is, sorry. Having to amortize your R&D credits across five years is deadly to cash flow. The only EU country with a law like this is Belgium.